AUTOLOMATE
Live / Registered — Registered (as of 15 Feb 2022)
What this means for you
Registered since 15 Feb 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79301893
- Registration number
- 6641505
- Mark type
- Stylized text
- Filed
- 28 Oct 2020
- Published for opposition
- 30 Nov 2021
- Registered
- 15 Feb 2022
- Attorney of record
- Michelle Alvey
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable computer software for digitizing records, scheduling of all critical manufacturing criteria, including inbound starting material, availability and assignment of manufacturing operatives, availability and assignment of manufacturing equipment, and availability and assignment of GMP cleanroom, and quality approval of the manufacturing processes and specification of the drug product in the field of cell and gene therapy; recorded and downloadable computer software platforms for autologous medicines for digitizing records, scheduling of all critical manufacturing criteria, including inbound starting material, availability and assignment of manufacturing operatives, availability and assignment of manufacturing equipment, and availability and assignment of GMP cleanroom and quality approval of the manufacturing processes and specification of the drug product; downloadable computer software that enables users to digitise, upload and automate information relating to cell and gene therapy
- Class 035 — Advertising and business services: Data management services in relation to autologous medicines, namely, electronic data collection and data submission services for business purposes in the field of autologous medicines; compilation of information relating to gene and cell therapy into computer databases; data hub services, namely, data processing services and management and compilation of computerised databases; systemization of information relating to autologous medicines into computer databases
- Class 042 — Scientific and technological services: Platform as a service (PAAS) featuring computer software platforms for autologous medicines for digitizing records, scheduling of all critical manufacturing criteria, including inbound starting material, availability and assignment of manufacturing operatives, availability and assignment of manufacturing equipment, and availability and assignment of GMP cleanroom and quality approval of the manufacturing processes and specification of the drug product in the field of cell and gene therapy; software as a service (SAAS) services featuring software for autologous medicines for digitizing and downloading records, scheduling of all critical manufacturing criteria, including inbound starting material, availability and assignment of manufacturing operatives, availability and assignment of manufacturing equipment, and availability and assignment of GMP cleanroom, and quality approval of the manufacturing processes and specification of the drug product in the field of cell and gene therapy; providing software as a service (SAAS) services featuring software that enables users to digitise, upload, download, and automate information relating to gene and cell therapy
Owner
- Autolomous Ltd, GB
- Autolomous Ltd, GB
- Autolomous Ltd, GB
Prosecution history
- 16 Aug 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 21 Jul 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 21 Jul 2022 — FINAL DISPOSITION PROCESSED
- 15 May 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 15 Feb 2022 — REGISTERED-PRINCIPAL REGISTER
- 06 Dec 2021 — NOTIFICATION PROCESSED BY IB
- 30 Nov 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Nov 2021 — PUBLISHED FOR OPPOSITION
- 17 Nov 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 17 Nov 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 10 Nov 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Oct 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Oct 2021 — EXAMINER'S AMENDMENT ENTERED
- 25 Oct 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 25 Oct 2021 — EXAMINERS AMENDMENT E-MAILED